12 , 14 , 22 , 23 , 26 Baseline characteristics for each study are summarized in Table 1, 12 - 14 , 18 - 26 and data on the rates of inadequate bowel preparation, repeat CLNs, and mean BBPS differences are presented in Table 2
Research Use Only The peptides tested are intended for research use only and are not approved for human or veterinary use, diagnostic, therapeutic, or clinical applications
Growth hormone changes bone geometry and body composition in patients with juvenile idiopathic arthritis requiring glucocorticoid treatment: a controlled study using peripheral quantitative computed tomography
Alternative diabetes medications or weight management strategies exist, and your healthcare team can discuss options that balance metabolic benefits against tolerability
The role of prolactin receptor in GH signaling in breast cancer cells
As with earlier GLP-1 agents, any sexual side effects will likely be dose-dependent, reversible, and patient-specific